Position in INVA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$94,496,225
+$10,334,887 QoQ
Shares Held
4,055,632
-3.7% QoQ
Ownership
5.49%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,448,283,094 across 327 Biotechnology names. INVA ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
This page
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in INVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $94,496,225 | 4,055,632 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $84,161,338 | 4,210,172 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $83,711,509 | 4,586,932 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $95,645,114 | 4,760,832 | Shares | Sole | 2025-08-13 | |
| 2025-04-01 | $85,409,326 | 4,760,832 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $82,622,616 | 4,557,232 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $73,941,050 | 4,261,732 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $83,610,504 | 4,329,907 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $70,944,874 | 4,325,907 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $66,528,802 | 4,365,407 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $66,476,929 | 4,144,447 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $51,952,296 | 3,999,407 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $48,995,822 | 3,848,847 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $44,101,653 | 3,920,147 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $56,042,292 | 4,229,607 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $49,524,463 | 4,265,673 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $70,832,841 | 4,798,973 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $100,883,798 | 5,213,633 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $91,341,044 | 5,295,133 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $90,976,625 | 5,444,442 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $78,816,497 | 5,877,442 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $90,612,571 | 7,582,642 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $97,655,526 | 7,881,802 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $87,723,684 | 8,394,611 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $119,260,737 | 8,530,811 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $96,479,169 | 8,204,011 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||